Cervical Cancer clinical trials in Hawaii

3 actively recruiting cervical cancer trials at 3 sites across Hawaii.

Data from ClinicalTrials.gov · last refreshed 2026-07-07

Phase 2 Recruiting Network

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

This phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IVA squamous cell carcinoma of the head and neck who have undergone surgery. Radiation therapy uses high energy x-ra…

Sponsor: ECOG-ACRIN Cancer Research Group

NCT ID: NCT02734537

Sites in Hawaii:

Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii
Island Urology — Honolulu, Hawaii
Queen's Cancer Cenrer - POB I — Honolulu, Hawaii
Queen's Medical Center — Honolulu, Hawaii
Straub Clinic and Hospital — Honolulu, Hawaii

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamous cell head and neck cancer that may have spread from where it first started to…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT05136196

Sites in Hawaii:

Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii
Queen's Cancer Cenrer - POB I — Honolulu, Hawaii
Queen's Medical Center — Honolulu, Hawaii
Queen's Cancer Center - Kuakini — Honolulu, Hawaii
Hawaii Cancer Care - Westridge — ‘Aiea, Hawaii

View on ClinicalTrials.gov →

Phase 2 Recruiting Academic/Other

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

This phase II trial compares the effect of usual treatment of docetaxel chemotherapy plus trastuzumab, to ado-emtansine (T-DM1) in patients with HER2-postive salivary gland cancer that has come back (recurrent), that has spread from where …

Sponsor: NRG Oncology

NCT ID: NCT05408845

Sites in Hawaii:

Kaiser Permanente Moanalua Medical Center — Honolulu, Hawaii

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-07-07